The Pancreatic Cancer Early Detection (PRECEDE) Study is a Global Effort to Drive Early Detection: Baseline Imaging Findings in High-Risk Individuals

CONCLUSIONS: PRECEDE provides infrastructure support to increase access to clinical surveillance for HRIs worldwide, while aiming to drive early PC detection advancements through longitudinal standardized clinical data, imaging, and biospecimen captures. Increased cyst prevalence in HRIs with FPC suggests that FPC may infer distinct biological processes. To enable the development of PC surveillance approaches better tailored to risk category, we recommend adoption of subclassification of HRIs into FPC, PGV+/FPC+, and PGV+/FPC- risk groups by surveillance protocols.PMID:38626807 | DOI:10.6004/jnccn.2023.7097

Source: Journal of the National Comprehensive Cancer Network : JNCCN - April 16, 2024 Category: Cancer & Oncology Authors: George Zogopoulos Ido Haimi Shenin A Sanoba Jessica N Everett Yifan Wang Bryson W Katona James J Farrell Aaron J Grossberg Salvatore Paiella Kelsey A Klute Yan Bi Michael B Wallace Richard S Kwon Elena M Stoffel Raymond C Wadlow Daniel A Sussman Nipun B M Source Type: research